Literature DB >> 48728

High blood-pressure: a risk factor for cancer mortality?

A R Dyer, J Stamler, D M Berkson, H A Lindberg, E Stevens.   

Abstract

Univariate and multivariate analyses have been made of the relationship of systolic and diastolic blood-pressure measured at study entry to subsequent 14-year mortality among 1233 White males originally age 40-59 in 1958 from the Chicago Peoples Gas Company prospective study. With age, serum-cholesterol, and cigarettes per day controlled, both elevated systolic and electaed diastolic blood-pressure in 1958 were found to be strongly related to subsequent mortality from cancer in the men of this study. The possibility that this finding was due either to an association between antihypertensive medication in general, and cancer, or to an association was found that could explain the excess cancer mortality among those with elevated blood-pressure in 1958, either with medication in general, or with reserpine and rauwolfia in particular. These findings thus pose the question, is high blood-pressure associated with an increased risk of death due to cancer?

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 48728     DOI: 10.1016/s0140-6736(75)91826-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

Review 1.  Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.

Authors:  M Pahor; C D Furberg
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

Review 2.  Calcium antagonists and cancer. Is there really a link?

Authors:  L G Howes; C T Edwards
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

3.  Analysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancer.

Authors:  Pei Yang; Weiye Deng; Yaqian Han; Yingrui Shi; Ting Xu; Juan Shi; Hesham Elhalawani; Yu Zhao; Xiaoxue Xie; Fan Lou; Rong Zhang; Hekun Jin
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

4.  In-Hospital Mortality and Post-Surgical Complications Among Cancer Patients with Metabolic Syndrome.

Authors:  Tomi Akinyemiju; Swati Sakhuja; Neomi Vin-Raviv
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

5.  The case for developmental gerontology--Thompson's octad.

Authors:  M K Thompson
Journal:  J R Coll Gen Pract       Date:  1986-01

Review 6.  Carcinogenicity of antihypertensive therapy.

Authors:  Ehud Grossman; Franz H Messerli; Uri Goldbourt
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

7.  Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response.

Authors:  S Sud; C O'Callaghan; C Jonker; C Karapetis; T Price; N Tebbutt; J Shapiro; G Van Hazel; N Pavlakis; P Gibbs; M Jeffrey; L Siu; S Gill; R Wong; D Jonker; D Tu; R Goodwin
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

8.  High blood pressure related to carcinogen-induced unscheduled DNA synthesis, DNA carcinogen binding, and chromosomal aberrations in human lymphocytes.

Authors:  R W Pero; C Bryngelsson; F Mitelman; T Thulin; A Nordén
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

9.  Is serum selenium a risk factor for cancer?

Authors:  I Peleg; S Morris; C G Hames
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

10.  Retrospective evaluation of weekly paclitaxel hypersensitivity reactions reported utilizing an electronic medical record system at a tertiary cancer center.

Authors:  Lincy S Lal; Donna L Gerber; Jason Lau; William Dana
Journal:  Support Care Cancer       Date:  2009-01-30       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.